1. Volume 151, Issue 6, Pages 1155-1163.e2 (December 2016)
Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma 
Riad Salem, Andrew C. Gordon, Samdeep Mouli, Ryan Hickey, Joseph Kallini, Ahmed Gabr, Mary F. Mulcahy, Talia Baker, Michael Abecassis, Frank H. Miller, Vahid Yaghmai, Kent Sato, Kush Desai, Bartley Thornburg, Al B. Benson, Alfred Rademaker, Daniel Ganger, Laura Kulik, Robert J. Lewandowski 
Gastroenterology 
Volume 151, Issue 6, Pages e2 (December 2016)
DOI: /j.gastro
Copyright © 2016 AGA Institute Terms and Conditions

2. Figure 1 Time to progression.
Gastroenterology  , e2DOI: ( /j.gastro )
Copyright © 2016 AGA Institute Terms and Conditions

3. Figure 2
Waterfall plot of maximum size change for WHO measurements in (n = 42) primary index lesions after Y90 (black bars) vs cTACE (white bars). Negative values represent reductions in tumor size with a 50% or greater reduction (-) defined as a partial response and a more than 25% increase (+) in size defined as progressive disease.
Gastroenterology  , e2DOI: ( /j.gastro )
Copyright © 2016 AGA Institute Terms and Conditions

4. Figure 3
Overall survival from randomization censored to liver transplantation.
Gastroenterology  , e2DOI: ( /j.gastro )
Copyright © 2016 AGA Institute Terms and Conditions

5. Supplementary Figure 1 CONSORT study flowchart.
Gastroenterology  , e2DOI: ( /j.gastro )
Copyright © 2016 AGA Institute Terms and Conditions